ANDA 77011, held by Hikma. Ondansetron Hydrochloride.
As of Nov 16, 2026, ANDA 77011 (Ondansetron Hydrochloride Preservative Free), held by Hikma, was first approved by FDA on Dec 26, 2006, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 26, 2006 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Ondansetron Hydrochloride Preservative FreeEQ 2MG BASE/ML · injectable;injection | Ondansetron Hydrochloride | Rx |
| Apr 3, 2013 | Supplement 6Labeling · Standard review | Approved | None posted |
| Apr 3, 2013 | Supplement 8Labeling · Standard review | Approved | None posted |
| Nov 30, 2010 | Supplement 1Labeling | Approved | None posted |
| Nov 30, 2010 | Supplement 2Labeling | Approved | None posted |
| Dec 26, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters